Could you send me an application form? <a href=" http://www.oxfordbar.co.uk/nexium-price-comparison.pdf#lucky ">nexium drug category</a> Celgene said it now expects adjusted full-year earnings of$5.90 per share to $5.95 per share, up from its prior view of$5.80 to $5.90 and marking the third time this year that thecompany has boosted its 2013 forecast.